Femoropopliteal Artery Disease
Conditions
Interventions
1:TurboHawk atherectomy
2:drug-coated balloon
Sponsors
Beijing Chaoyang Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with age > 18 years old and < 85 years old, both male and female; 2. Rutherford grade: 2-5; 3. Patients with stenosis more than 70% and lesion length more than 40mm or P1 popliteal artery disease; 4. Patients with vessel diameter of 4-8mm; 5. Patients with at least one branch of blood flow in the outlet of 3 branches under the knee; 6. Patients who voluntarily participate in the clinical trial, accept the experimental intervention measures, and are willing to follow up regularly.
Exclusion criteria
Exclusion criteria: 1. Patients whose guide wire cannot pass through the lesion; 2. Patients with severe current limiting dissection or more than 70% stenosis after pre expansion; 3. Patients with severe renal insufficiency (serum creatinine > 2.5 mg / dl); 4. Patients allergic to aspirin, heparin, clopidogrel, paclitaxel and contrast media; 5. Patients with planned amputation; 6. Patients with life expectancy less than 1 year; 7. Patients who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary patency;Clinically-driven target lesion revascularization; | — |
Secondary
| Measure | Time frame |
|---|---|
| Technical success;Complication;Ankle-brachial index; | — |
Countries
China
Contacts
Public ContactChuanjun Liao
Beijing Chaoyang Hospital Affiliated to Capital Medical University
Outcome results
None listed